Instant rule-out of suspected non-ST-segment elevation myocardial infarction using high-sensitivity cardiac troponin T with Copeptin versus a single low high-sensitivity cardiac troponin T: findings from a large pooled individual data analysis on 10,329 patients
Evidence is sparse and inconsistent on the role of a dual marker strategy (DMS) combining Copeptin with cardiac troponin T (cTnT) for instant rule-out of a non-ST-segment myocardial infarction (NSTEMI) when high sensitivity cardiac troponin T (hs-cTnT) is used.
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2021
|
| In: |
Clinical research in cardiology
Year: 2021, Jahrgang: 110, Heft: 2, Pages: 194-199 |
| ISSN: | 1861-0692 |
| DOI: | 10.1007/s00392-020-01712-y |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00392-020-01712-y
|
| Verfasserangaben: | Evangelos Giannitsis, K. Huber, C.W. Hamm, M. Möckel |
| Zusammenfassung: | Evidence is sparse and inconsistent on the role of a dual marker strategy (DMS) combining Copeptin with cardiac troponin T (cTnT) for instant rule-out of a non-ST-segment myocardial infarction (NSTEMI) when high sensitivity cardiac troponin T (hs-cTnT) is used. |
|---|---|
| Beschreibung: | Published online: 15 July 2020 Gesehen am 07.10.2021 |
| Beschreibung: | Online Resource |
| ISSN: | 1861-0692 |
| DOI: | 10.1007/s00392-020-01712-y |